CLOMAGEV Trademark

Trademark Overview

On Friday, January 25, 2008, a trademark application was filed for CLOMAGEV with the United States Patent and Trademark Office. The USPTO has given the CLOMAGEV trademark a serial number of 77380382. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 2, 2016. This trademark is owned by GlaxoSmithKline Biologicals, S.A.. The CLOMAGEV trademark is filed in the Pharmaceutical Products category with the following description:

VACCINES FOR HUMAN USE
clomagev

General Information

Serial Number77380382
Word MarkCLOMAGEV
Filing DateFriday, January 25, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 2, 2016
Registration Number3741550
Registration DateTuesday, January 26, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2009

Trademark Statements

Goods and ServicesVACCINES FOR HUMAN USE
Translation of Words in Mark"CLOMAGEV" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 2, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals, S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals, S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Friday, September 2, 2016CANCELLED SEC. 8 (6-YR)
Monday, June 8, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 8, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 26, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2009PUBLISHED FOR OPPOSITION
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 7, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 5, 2009ASSIGNED TO LIE
Monday, October 5, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 2, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 1, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 1, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 8, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 8, 2009INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 8, 2009SUSPENSION INQUIRY WRITTEN
Monday, April 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 6, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, April 6, 2009ASSIGNED TO LIE
Monday, October 6, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 6, 2008LETTER OF SUSPENSION E-MAILED
Monday, October 6, 2008SUSPENSION LETTER WRITTEN
Monday, September 29, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 29, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 29, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 6, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 6, 2008NON-FINAL ACTION E-MAILED
Tuesday, May 6, 2008NON-FINAL ACTION WRITTEN
Monday, May 5, 2008ASSIGNED TO EXAMINER
Tuesday, January 29, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

clomagev human vaccines